BlossomHill Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for BlossomHill Therapeutics, Inc. (BLSM) is 294.71M

According to BlossomHill Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 294.71M. This represents a change of 20.37% compared to the average of 244.83M of the last 4 quarters.

BlossomHill Therapeutics, Inc. (BLSM) Historical Enterprise Value (quarterly & annually)

How has BLSM Enterprise Value performed in the past?

The mean historical Enterprise Value of BlossomHill Therapeutics, Inc. over the last ten years is 358.35M. The current 294.71M Enterprise Value has changed -17.76% with respect to the historical average. Over the past ten years (40 quarters), BLSM's Enterprise Value was at its highest in in the March 2026 quarter at 372.32M. The Enterprise Value was at its lowest in in the March 2025 quarter at 0.

BlossomHill Therapeutics, Inc. (BLSM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BlossomHill Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BlossomHill Therapeutics, Inc. (BLSM) Average Enterprise Value

How has BLSM Enterprise Value performed in the past?

The current Enterprise Value of BlossomHill Therapeutics, Inc. (BLSM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BlossomHill Therapeutics, Inc. (BLSM) Enterprise Value vs. Peers

How is BLSM’s Enterprise Value compared to its peers?

BlossomHill Therapeutics, Inc.’s Enterprise Value is greater than Actuate Therapeutics Inc (4.61M), greater than Prelude Therapeutics Incorporated (152.10M), greater than Foghorn Therapeutics Inc. (95.91M), less than Agios Pharmaceuticals, Inc. (1.78B), less than Relay Therapeutics, Inc. (3.76B), less than Nurix Therapeutics, Inc. (2.17B), less than Monte Rosa Therapeutics, Inc. (851.78M), less than Faeth Therapeutics, Inc. (457.04M), greater than Allarity Therapeutics, Inc. (19.62M), less than ArriVent BioPharma, Inc. (534.50M),

Build a custom stock screener for BlossomHill Therapeutics, Inc. (BLSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BlossomHill Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BlossomHill Therapeutics, Inc. (BLSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BlossomHill Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.